ArTara Therapeutics Aktie
WKN DE: A2PX49 / ISIN: US04300J1079
|
05.03.2025 14:10:36
|
Protara Therapeutics, Inc. Q4 Loss Beats Estimates
(RTTNews) - Protara Therapeutics, Inc. (TARA) revealed Loss for fourth quarter that beat the Street estimates.
The company's earnings totaled -$12.77 million, or -$0.48 per share. This compares with -$10.22 million, or -$0.90 per share, last year.
Analysts on average had expected the company to earn -$0.56 per share. Analysts' estimates typically exclude special items.
Protara Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$12.77 Mln. vs. -$10.22 Mln. last year. -EPS: -$0.48 vs. -$0.90 last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ArTara Therapeutics Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |